Industry Takes Steps to Prevent Counterfeit Drugs
The fight against counterfeit drugs is an international effort, as exemplified by the ‘Fight the Fakes’ campaign.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development
Customers are looking to reduce risk, increase performance, and optimize productivity.

Advertisement: As the innovative leader in tablet compression tooling, presses, accessories, and services, Natoli Engineering Company strives to provide customers with new ways to keep in touch, stay educated, and ease the order process. Our completely redesigned website features simpler navigation, online quoting with photos of press parts and accessories, and more! Search Natoli’s parts catalog by OEM part number, manufacturer, and machine. Learn more

CPhI Worldwide to Host Tweetchat #CPhIChat on Key Issues Facing the Pharma Industry
CPhI Worldwide is launching #CPhIChat, a global industry-wide Tweetchat aimed to facilitate conversations on key issues facing the pharmaceutical industry.

Innova BioSciences Introduces InnovaGOLD Nanoparticles
New ultra-high quality gold nanoparticles simplify assay development and improve the sensitivity of immunoassays.

Advertisement: Worry-free weighing: Dealing with static and drafts Thursday, October 9, 2014 at 11:00 AM EDT To Register Free:www.pharmtech.com/worry

Catalent Collaborates with Minomic to Develop Prostate Cancer Treatment
Catalent and Minomic collaborate to develop MIL-38, an antibody drug conjugate for prostate cancer therapy using GPEx technology.

Pfizer Announces Approval of ELELYSO in Treatment of Type 1 Gaucher Disease
Pfizer announced that FDA approved ELELYSO for treatment of Type 1 Gaucher disease in adult and pediatric patients.

Ionic Liquids Shown to Break Bacterial Biofilm Layer
Los Alamos National Laboratory tests ionic liquids that could resolve serious skin infections.

Teva Announces Positive Results from Clinical Asthma Treatment Trials
Teva's reslizumab delivers clinically and statistically significant reduction in Asthma exacerbations in two pivotal phase III studies.

Pfizer's Vaccine for C. Difficile Receives FDA Fast Track Designation
Pfizer announced that its investigational vaccine candidate for the treatment of Clostridium difficile has been granted the Fast Track designation from FDA.

Coperion K-Tron, Hosokawa and Sly Inc. Offer Milling and Material Handling Seminar
Coperion K-Tron, Hosokawa, and Sly will host a technical seminar and product demonstrations on milling and material handling on Oct. 14-15 at Hosokawa Facility in Summit, NJ.